Canakinumab for systemic-onset juvenile idiopathic arthritis/Still's disease-effectiveness and safety data from the BiKeR registry.

EULAR Rheumatol Open · 2026 · PMC13425002 · PMID 42540060

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

As outlined in Figure 4 , we found a weak correlation, which was significant for the month 6 but borderline significant for the month 12 data.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.